Skip to main content
. 2020 Nov 27;20:897. doi: 10.1186/s12879-020-05605-3

Table 1.

Characteristics of patients at admission

All patients
(n = 319)
Discharged
(n = 238)
Deceased
(n = 81)
p-value
Baseline and demographic parameters
 Median age (IQR) — yr 74 (61–83) 71 (59–79) 82 (76–86) < 0.0001
 Male — no. (%) 188 (58.93) 138 (57.98) 50 (61.73) 0.5530
 Nursing home resident — no. (%) 30/318 (9.43) 17/137 (7.17) 13/81 (16.05) 0.0249
 Smoking history
  - Current smoker — no. (%) 20/181 (11.05) 18/131 (13.74) 2/50 (4.00) 0.0619c
  - Former smoker — no. (%) 63/181 (34.81) 42/131 (32.06) 21/50 (42.00) 0.2131
  - Never smoker— no. (%) 98/181 (54.14) 71/131 (54.20) 27/50 (54.00) 0.9809
 BMI (IQR) 26.75 (23.79–29.74) 26.35 (23.72–29.19) 28.17 (23.83–30.97) 0.0472
  - Underweighta - no. (%) 4/230 (1.74) 3/174 (1.72) 1/56 (1.79)
  - Normal weighta - no. (%) 80/230 (34.78) 63/174 (36.21) 17/56 (30.36) 0.4206
  - Overweighta - no. (%) 92/230 (40.00) 73/174 (41.95) 19/56 (33.93) 0.2830
  - Obesitya — no. (%) 54/230 (23.48) 35/174 (20.11) 19/56 (33.93) 0.0390
  - Not known 89 64 25
 Diabetes — no. (%) 65 (20.38) 38 (15.97) 27 (33.33) 0.0012
 Hypertension — no. (%) 162 (50.78) 101 (42.44) 61 (75.31) < 0.0001
  - Use of ACE inhibitor 60/251 (23.90) 39/178 (21.91) 21/73 (28.77) 0.2530
  - Use of ATII antagonist 30/250 (12.00) 18/177 (10.17) 12/73 (16.44) 0.1764
 COPD — no. (%) 40 (12.54) 27 (11.34) 13 (16.05) 0.2805
 Asthma — no. (%) 16 (5.02) 12 (5.04) 4 (4.94) 0.9286c
 Coronary artery disease — no. (%) 72 (22.57) 47 (19.75) 25 (30.86) 0.0434
 Chronic renal disease — no. (%) 62/318 (19.50) 34/237 (14.35) 28/81 (34.57) 0.0001
  - eGFR 30–60 36/314 (11.46) 26/233 (11.16) 10/81 (12.35) 0.7743
  - eGFR 15–30 17/314 (5.41) 5/233 (2.15) 12/81 (14.81) < 0.0001
  - eGFR < 15 3/314 (0.96) 0/233 (0.00) 3/81 (3.70) 0.0090c
  - HD/PD 7 (2.19) 4 (1.68) 3 (3.70) 0.2582c
 Cerebrovascular disease — no. (%) 48 (15.05) 30 (12.61) 18 (22.22) 0.0433
 Immunocompromised — no. (%) 42 (13.17) 32 (13.45) 10 (12.35) 0.7992
  - Immunosuppressive drugs 31 (9.72) 23 (9.66) 8 (9.88) 0.9556
  - Active chemotherapy 16 (5.02) 10 (4.20) 6 (7.41) 0.2727
Clinical symptoms
 Mean duration of symptoms (IQR) – days 7 (3–10) 7 (4–10) 4 (1–7) 0.0007
   - Not known 30 21 9
 History of feverb — no. (%) 191 (59.87) 148 (62.18) 43 (53.09) 0.1510
 Cough — no. (%) 211 (66.14) 161 (67.65) 50 (61.73) 0.3339
   - purulent 47 (14.73) 36 (15.13) 11 (13.58) 0.7327
 Dyspnea — no. (%) 208 (65.20) 152 (63.87) 56 (69.14) 0.3867
 Thoracic pain — no. (%) 29 (9.09) 26 (10.92) 3 (3.70) 0.0488c
 Myalgia — no. (%) 61 (19.12) 57 (23.95) 4 (4.94) < 0.0001c
 Diarrhea — no. (%) 49 (15.36) 38 (15.97) 11 (13.58) 0.6029
 Abdominal pain— no. (%) 25 (7.84) 20 (8.40) 6 (6.17) 0.5088
 Anorexia — no. (%) 93 (29.15) 76 (31.93) 17 (20.99) 0.0556
 Nausea — no. (%) 55 (17.24) 45 (18.91) 10 (12.35) 0.1644
 Vomiting — no. (%) 45 (14.11) 37 (15.55) 8 (9.88) 0.1908
 Syncope — no. (%) 12 (3.76) 8 (3.36) 4 (4.94) 0.4583c
 Headache — no. (%) 35 (10.97) 32 (13.45) 3 (3.70) 0.0117c
 Confusion — no. (%) 29 (9.09) 20 (8.40) 9 (11.11) 0.4728
 History of falling — no. (%) 19 (5.96) 8 (3.36) 11 (13.58) 0.0019
 Anosmia — no. (%) 20 (6.27) 18 (7.56) 2 (2.47) 0.1103c
Parameters
 Temperature > 38 °C – no. (%) 52 (16.30) 41 (17.23) 11 (13.58) 0.4354
 Respiratory rate (IQR) – breaths per min 16 (14–20) 16 (15–20) 16 (14–18) 0.5534
  - Not measured 25 16 9
 Mean arterial blood pressure (IQR) - mmHg 94 (84–102) 93 (84–102) 97 (83–104) 0.6908
  - Not measured 7 3 4

aBody mass index (the weight in kilograms divided by the square of the height in meters) was categorized as: < 18.5, underweight; 18.5–25, normal weight; 25–30, overweight; > 30 obese

bFever was defined as a measured body temperature > 38.0 °C

cUnivariate logistic regression used Firth correction when small cell counts (< 5) occurred